REVAGENIX INC
Federal contractor profile
Total Awards
2
Total Obligated
$44.8M
Agencies Served
1
Expiring Contracts
2
Top Agencies
| Agency | Awards | Total Obligated |
|---|---|---|
| Department of Health and Human Services | 2 | $44.8M |
Top NAICS Codes
| NAICS Code | Description | Awards |
|---|---|---|
| 541715 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) | 2 |
Expiring Contracts (2)
75N93020C00018131 days remaining
TO SELECT A NOVEL SMALL MOLECULE ANTIBIOTIC FOR CLINICAL DEVELOPMENT AND ADVANCE IT THROUGH IND FILING AND PHASE 1 CLINICAL STUDIES.
Department of Health and Human Services|Expires Aug 31, 2026
$26.9M
75N93022C00061161 days remaining
A NOVEL LPXC INHIBITOR WITH PAN-RESISTANT PSEUDOMONAS AND BURKHOLDERIA ACTIVITY.
Department of Health and Human Services|Expires Sep 30, 2026
$17.9M
All Awards
COST PLUS FIXED FEENO SET ASIDE USED.
TO SELECT A NOVEL SMALL MOLECULE ANTIBIOTIC FOR CLINICAL DEVELOPMENT AND ADVANCE IT THROUGH IND FILING AND PHASE 1 CLINICAL STUDIES.
Department of Health and Human Services75N93020C00018$26.9M
COST PLUS FIXED FEENO SET ASIDE USED.
A NOVEL LPXC INHIBITOR WITH PAN-RESISTANT PSEUDOMONAS AND BURKHOLDERIA ACTIVITY.
Department of Health and Human Services75N93022C00061$17.9M